Top Research Studies on GLP-1s and Cardiovascular Outcomes The November 2023 issue of The New England Journal of Medicine shared results from a research study (SELECT) involving 17,000 patients that showed the use of semaglutide was linked to a 20% reduction in the risk of major adverse cardiovascular events such as heart disease, stroke and peripheral arterial disease in patients who had previously been diagnosed with heart disease
Zhang Y, Qi Y, Li Y, Zhang Y, Zhao Y, Han H, Wang Y
In the present study, 55 diverse okra genotypes were evaluated using randomized complete block design to assess the genetic parameters of various nutritional and quality traits
Ro tries to avoid direct promotion of GLP-1s by removing the label from the packaging
Lung function phenotypes can neither distinguish between obstruction in the small airways and emphysematous destruction of the lung parenchyma nor provide information about regional differences in disease severity
